235 related articles for article (PubMed ID: 26415733)
1. PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.
Liao BY; Wang Z; Hu J; Liu WF; Shen ZZ; Zhang X; Yu L; Fan J; Zhou J
Tumour Biol; 2016 Mar; 37(3):2987-98. PubMed ID: 26415733
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model.
Feng YX; Wang T; Deng YZ; Yang P; Li JJ; Guan DX; Yao F; Zhu YQ; Qin Y; Wang H; Li N; Wu MC; Wang HY; Wang XF; Cheng SQ; Xie D
Hepatology; 2011 Feb; 53(2):483-92. PubMed ID: 21274870
[TBL] [Abstract][Full Text] [Related]
3. Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma.
Chen B; Chen XP; Wu MS; Cui W; Zhong M
Eur J Med Res; 2014 Aug; 19(1):45. PubMed ID: 25149140
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between serum matrix metalloproteinase-2 and metastasis and recurrence following radical hepatic resection in hepatocellular carcinoma].
Niu Q; Tang Z; Ma Z; Qin L; Bao W; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():58-60. PubMed ID: 11509142
[TBL] [Abstract][Full Text] [Related]
5. Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
Zhang J; Yang JM; Wang HJ; Ru GQ; Fan DM
PLoS One; 2013; 8(1):e52940. PubMed ID: 23308126
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
7. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells.
Chen XP; Luo JS; Tian Y; Nie CL; Cui W; Zhang WD
Biomed Res Int; 2015; 2015():241983. PubMed ID: 26839882
[TBL] [Abstract][Full Text] [Related]
9. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway.
Takeishi K; Taketomi A; Shirabe K; Toshima T; Motomura T; Ikegami T; Yoshizumi T; Sakane F; Maehara Y
J Hepatol; 2012 Jul; 57(1):77-83. PubMed ID: 22425622
[TBL] [Abstract][Full Text] [Related]
10. Significance of thymidine phosphorylase in HCC with chronic liver disease for long-term postoperative recurrence.
Ezaki T; Ikegami T; Ishida T; Aimitsu S; Mori M; Fujihara M
J Surg Oncol; 2003 Jul; 83(3):173-9; discussion 179. PubMed ID: 12827687
[TBL] [Abstract][Full Text] [Related]
11. Genistein reinforces the inhibitory effect of Cisplatin on liver cancer recurrence and metastasis after curative hepatectomy.
Chen P; Hu MD; Deng XF; Li B
Asian Pac J Cancer Prev; 2013; 14(2):759-64. PubMed ID: 23621233
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model.
Liu M; Zhang Y; Liao Y; Chen Y; Pan Y; Tian H; Zhan Y; Liu D
Cancer Biother Radiopharm; 2015 Aug; 30(6):233-9. PubMed ID: 26132704
[TBL] [Abstract][Full Text] [Related]
13. Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.
Huang GL; Li BK; Zhang MY; Wei RR; Yuan YF; Shi M; Chen XQ; Huang L; Zhang HZ; Liu W; Huang BJ; Li H; Zheng XF; Luo XR; Wang HY
PLoS One; 2012; 7(8):e44061. PubMed ID: 22952874
[TBL] [Abstract][Full Text] [Related]
14. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy.
Donadon M; Di Tommaso L; Soldani C; Franceschini B; Terrone A; Mimmo A; Vitali E; Roncalli M; Lania A; Torzilli G
Liver Int; 2018 Feb; 38(2):303-311. PubMed ID: 28727243
[TBL] [Abstract][Full Text] [Related]
15. [Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells].
Chen X; Ye R; Dai D; Wu Y; Yu Y; Cheng B
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1065-1071. PubMed ID: 32895190
[TBL] [Abstract][Full Text] [Related]
16. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
[TBL] [Abstract][Full Text] [Related]
17. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
[TBL] [Abstract][Full Text] [Related]
19. Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.
Peng B; Liang L; Chen Z; He Q; Kuang M; Zhou F; Lu M; Huang J
Hepatogastroenterology; 2006; 53(69):409-14. PubMed ID: 16795983
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
